Influence of the comprehensive geriatric assessment (CGA) in elderly metastatic cancer patients. Analysis from a prospective cohort of 1048 patients.

Authors

null

Rabia Boulahssass

Centre hospitalier de Nice, Nice, France

Rabia Boulahssass , Sebastien Gonfrier , Bereder Isabelle , Ludovic Evesque , Andre Gary , Jean Michel Hannoun Levi , Delphine Borchiellini , Patrice Brocker , Gerard Cavaglione , Emmanuel Barranger , Emmanuel Benizri Jr., Anne-Claire Frin , Anne Creisson , Thomas Kreitmann , jean-Louis Bernard Sr., Gilles Poissonnet , Jean Amiel , Joel Guigay , Eric Francois , Olivier Guerin

Organizations

Centre hospitalier de Nice, Nice, France, CHU de Nice, Nice, France, Centre Antoine Lacassagne, Nice, France, CRLCC Antoine-Lacassagne, Nice, France, Hopital Archet 2, Nice, France, Centre Hospitalier Universitaire de Nice, Nice, France, Centre Anticancereux Mougins, Mougins, France, Centre Antoine-Lacassagne, Nice, France, Department of Medical Oncology, Centre Antoine-Lacassagne, Nice, France

Research Funding

Other

Background: Previous studies were shown that the CGA influence the therapeutic decision and help in the care plan.Aims of this study are :1) Determine the influence of the CGA for the therapeutic decision in elderly metastatic cancers (MC). 2) To determine the impact of the CGA on guided geriatric interventions in MC Methods: The PACA East cohort is a multicentric and prospective cohort study approved by an ethics committee. At the baseline, a standardized CGA was performed (MMSE,MNA,Grip strength, ADL, IADL ,CIRSg,Charlson,lee,PS,Gait speed, QLQc30,G8,Balducci). During the follow up from April 2012 to October 2014, treatments made and guided interventions were collected. We collected the final decision, the rate and the type of modification according to the CGA in MC and in non MC for making a comparison. Results: In the cohort 312 patients had a MC with a median age of 82y. The CGA influence the therapeutic decision in 28% in MC (n = 312) versus 20% (n = 736) in non MC (p = 0,004).The CGA modified the decision for best supportive care (BSC) for 10% (n = 106) in this cohort (n = 1048) and in 17% (n = 55/312) in MC versus 7%(n = 51/736) in non MC (p < 0,001). The dependence on ADL and IADL was more found in elderly patients with MC (p = 0,042 /p = 0,007) and they had more nursing interventions (p < 0,001). Patients with MC had a worse QoL (p < 0,001) , more depression (p = 0,012) , poor PS (p < 0,001) and they have more psychological interventions (p = 0,01) and more specialized pain evaluation (p = 0,007). The G8 and the nutritional status assessed by the MNA were worse for patients with MC (p < 0,001) and they had more nutritional interventions (p = 0,001).We observed no significant differences regarding gait speed, isolation, balducci score and cognitive function but also no difference on rate of physiotherapist interventions, of social interventions and on modification of care course for rehabilitation by the geriatric team between the 2 groups. Conclusions: Guided geriatric interventions seems to be correlated to deficits assessed by the geriatrian. This study confirms the importance of the CGA in the decision , but also in the global care plan in patients with MC.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Geriatric Oncology

Citation

J Clin Oncol 34, 2016 (suppl; abstr 10045)

DOI

10.1200/JCO.2016.34.15_suppl.10045

Abstract #

10045

Poster Bd #

33

Abstract Disclosures

Similar Abstracts

First Author: Davide Bimbatti

Abstract

2021 ASCO Quality Care Symposium

Supportive care needs among older Mexican adults with metastatic cancer.

First Author: Ana Cristina Torres

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Prognostic factors for GEM + nab-PTX combination therapy in elderly patients with pancreatic cancer.

First Author: Kazuki Watabe